TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data
暂无分享,去创建一个
Sohrab P. Shah | Ali Bashashati | Marco A. Marra | Gavin Ha | Alan Le | Damian Yap | Karey Shumansky | Samuel Aparicio | Jessica N. McAlpine | Jamie Rosner | Andrew Roth | Justina Biele | Emma Laks | Jiarui Ding | Nataliya Melnyk | Andrew McPherson | A. Bashashati | M. Marra | S. Shah | S. Aparicio | A. McPherson | Jiarui Ding | G. Ha | Jamie Rosner | D. Huntsman | Andrew Roth | J. Khattra | C. Gilks | J. McAlpine | L. Prentice | N. Melnyk | D. Yap | E. Laks | Justina Biele | Julie Ho | K. Shumansky | Alan Le | Samuel Aparicio | Andrew W McPherson | Emma Laks | David G. Huntsman | C. Blake Gilks | Jaswinder Khattra | Julie Ho | Leah M. Prentice | Damian Boon Siew Yap | Sohrab P. Shah | Nataliya Melnyk
[1] Nicholas B. Larson,et al. PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data , 2013, Bioinform..
[2] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[3] P. Maxwell,et al. Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survival. , 2012, Cancer research.
[4] Michalis Vazirgiannis,et al. Clustering validity checking methods: part II , 2002, SGMD.
[5] A. Ashworth,et al. The DNA damage response and cancer therapy , 2012, Nature.
[6] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[7] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[8] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[9] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[10] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[11] Carlos Caldas,et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary , 2010, The Journal of pathology.
[12] Christopher Yau,et al. OncoSNP-SEQ: a statistical approach for the identification of somatic copy number alterations from next-generation sequencing of cancer genomes , 2013, Bioinform..
[13] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[14] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[15] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[16] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[17] R. Olson,et al. Abstract 5675: Potential use of proteosome pathway inhibitor (bortezomib) in combination with anthracyclines to treat multiple myeloma and pancreatic cancer , 2012 .
[18] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[19] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[20] J. Salk. Clonal evolution in cancer , 2010 .
[21] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[22] P. Campbell,et al. Single-cell mutational profiling and clonal phylogeny in cancer , 2013, Genome research.
[23] Tatiana Popova,et al. Supplementary Methods , 2012, Acta Neuropsychiatrica.
[24] Ali Bashashati,et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling , 2013, The Journal of pathology.
[25] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[26] Carlo C. Maley,et al. Clonal evolution in cancer , 2012, Nature.
[27] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[28] Lovelace J. Luquette,et al. Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes , 2013, Cell.
[29] Mark D. Johnson,et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion , 2011, Proceedings of the National Academy of Sciences.
[30] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[31] John Quackenbush,et al. Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome , 2012, Clinical Cancer Research.
[32] Oliver Sieber,et al. A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping data , 2010, Genome Biology.
[33] Benjamin J. Raphael,et al. THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data , 2013, Genome Biology.
[34] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[35] A. Bashashati,et al. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.
[36] Christopher J. R. Illingworth,et al. High-Definition Reconstruction of Clonal Composition in Cancer , 2014, Cell reports.
[37] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[38] M. Gerstung,et al. Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.
[39] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .